Jane Gakuru

9PUBLICATIONS
44CO-AUTHORS
Behavioural epidemiologyTumour immunologyMedical infection agents (incl. prions)NanomedicineImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 14, 2026
Once-Daily Dolutegravir-Based Antiretroviral Therapy Among Adults With Advanced HIV Disease Receiving 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis-Preventive Therapy and Fluconazole for Treatment of Cryptococcal Meningitis: Results of a Pharmacokinetic Study.

|Jan 13, 2026
Cerebrospinal Fluid Hypo-inflammation Drives Mortality in HIV-Associated Tuberculous Meningitis.

Anna L Wilt, David B Meya, Fiona V Cresswell

|Aug 21, 2025
Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-Week and 1-Year Survival Among Persons With HIV-Associated Cryptococcal Meningitis.

Morris K Rutakingirwa, Kenneth Ssebambulidde, Samuel Okurut

|Jan 08, 2025
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022.

Stewart Walukaga, Ann Fieberg, Abdu Musubire

|Oct 17, 2024
Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in Uganda.

John Kasibante, Eesha Irfanullah, Abduljewad Wele

|Aug 24, 2024
Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort Study.

Jane Gakuru, Enock Kagimu, Biyue Dai

Pageof 2

Frequent Collaborators

5 joint publications

Enock Kagimu

5 joint publications

Kenneth Ssebambulidde

5 joint publications

David R Boulware

5 joint publications

David B Meya